Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697035 | Brachytherapy | 2017 | 13 Pages |
Abstract
These recommendations may provide a clinical guidance regarding the use of boost after WBI in invasive breast cancer and holds for standard and hypofractionated WBI. Furthermore they should promote further clinical research focusing on controversial issues in the treatment of early-stage breast carcinoma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alfredo Polo, Csaba Polgár, Jean-Michel Hannoun-Levi, Jose-Luis Guinot, Cristina Gutierrez, Razvan Galalae, Erik van Limbergen, Vratislav Strnad,